Zaineb Hamzaoui, Sana Ferjani, Lamia Kanzari, Roua Ben Ali, Latifa Charaa, Ichrak Landolsi, Ines Medini, Sarra Chammam, Salma Abid, Asma Ferjani, Dhouha Kebaier, Ahmed Fakhfakh, Zoubeir Bouslah, Mouna Ben Sassi, Sameh Trabelsi, Ilhem Boutiba-Ben Boubaker
The JN.1 sub-variant is a new variant of the SARS-CoV-2 Omicron strain, derived from the BA.2.86 sub-variant. It was first detected in late 2023 and has quickly spread to many countries, becoming the most prevalent variant in some regions. JN.1 exhibits a unique mutation (L455S) in the spike protein compared to the BA.2.86 lineage, which may affect its transmissibility and immune evasion capabilities. JN.1 has been designated as a "variant of interest" by the World Health Organization due to its rapidly increasing spread and is being closely monitored for its impact on the COVID-19 pandemic...
May 8, 2024: Acta Microbiologica et Immunologica Hungarica